The global server PCB market is estimated to be valued at $48.61 BN in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Server PCB market are Bristol Myers Squibb, Merck and Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, and Rocket Medical. Bristol Myers Squibb is currently the market leader with the largest market share of 15%.

The growing Server PCB Market Demand for cloud-based services from industries like IT & telecom, BFSI, healthcare is fueling the sales of servers worldwide. Organizations are increasingly moving their infrastructure and applications to the cloud to gain efficiency and scalability. This is positively impacting the demand for server PCBs.

The server PCB market is witnessing high growth in the Asia Pacific region on account of rising digitalization, increasing investments in data center construction, and growing adoption of cloud computing in countries like China, India, and Japan. Key players are expanding their manufacturing facilities in the region to leverage the potential opportunities.

Get More Insights on Server PCB Market